Clinical Trials to Compare the Pharmacokinetic Profiles of Sarpogrelate hydrochloride 300mg SR Tablet and ANPLAG IR After Oral Administration to Healthy Male Subjects

Trial Profile

Clinical Trials to Compare the Pharmacokinetic Profiles of Sarpogrelate hydrochloride 300mg SR Tablet and ANPLAG IR After Oral Administration to Healthy Male Subjects

Recruiting
Phase of Trial: Phase I

Latest Information Update: 08 Sep 2016

At a glance

  • Drugs Sarpogrelate (Primary)
  • Indications Arterial occlusive disorders
  • Focus Pharmacokinetics
  • Sponsors KunWha Pharmaceutical
  • Most Recent Events

    • 08 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top